Leronlimab

Drug identity checked against registry records

Also recorded as Standard-of-care chemotherapy or radiotherapy

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid TumorsNCT04504942CytoDyn, Inc.Phase 2Completed2021-11-07Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.